DRAPER, Utah, Nov. 25, 2013 /PRNewswire/ -- Nutranomics,

New Post Public Reply Private Reply Replies (0) Message Board

Nov 25, 2013 at 10:28 AM

DRAPER, Utah, Nov. 25, 2013 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to announce that the Company has completed a Licence Agreement with Genesar Nutraceuticals, LLC ("Genesar") to acquire the worldwide exclusive marketing and distributing rights to GenEpic™, a natural therapeutic treatment formula currently the subject of an IRB reviewed (FDA regulated) phase II human clinical study on prostate cancer treatment and recovery. Under the terms of the Licence Agreement, Nutranomics will hold the worldwide licence for GenEpic™ including all intellectual property relating to it and any associated trade secrets for a period of thirty (30) years in exchange for the following: i) 100,000 restricted shares of NNRX common stock; ii) a royalty fee of $4.00/box of GenEpic™ sold by Nutranomics; and iii) payment of $200,000 as advance royalties on the first 4,000 boxes sold, due in December 2013. "We are extremely pleased to have finalized an agreement for the worldwide rights to GenEpic™ in advance of the completion of its current phase II human clinical study," stated Dr. Tracy K. Gibbs, Nutranomics CEO. "Following the successful completion of the study, we will be well-positioned to market and distribute GenEpic globally while leveraging the strength of an IRB reviewed human clinical study." GenEpic™ is a natural therapeutic formula containing 70 vitamins and minerals, 32 herbs, and 16 enzymes and phytonutrients, and formulated by a respected team of five scientists and natural medicine experts, including Dr. Gibbs. GenEpic™ is currently the subject of an IRB reviewed (FDA regulated) phase II human clinical study on prostate cancer treatment and recovery being conducted at OH Research Group in Salt Lake City, Utah. The Company expects the GenEpic™ phase II human clinical study to be completed within the next 60 days. Dr. Gibbs concluded, "It's very rare that a nutraceutical product like GenEpic™ is subjected to this kind of strict human clinical study. I look forward to using this fact to our advantage as we build awareness for the product globally among consumers and potential distributors." About Nutranomics Nutranomics is a publicly traded company engaged in research and development of nutritional food products. In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public. Nutranomics has also produced formulas for hundreds of other companies. Nutranomics' mission is to increase human health and longevity through education and self-awareness. The Company has sales representatives throughout North America and Asia. For further information regarding Nutranomics, Inc., please contact our investor relations representatives at ir@nutranomics.com or call toll-free (888) 616-3999. Notice Regarding Forward-Looking Statements This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, but are not limited to, the outcome of the GenEpic human clinical study and the implied potential for revenue and/or profits from GenEpic sales. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. SOURCE Nutranomics, Inc. Copyright 2013 PR Newswire

Nutranomics, Inc. (NNRX) Stock Research Links

NNRX Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GenesisFX Rolls Out Live Leaderboards, Boosts Social Trading

Traders buckle up! GenesisFX Markets just kicked open a new chapter in forex and CFD trading with their Live Leaderboards and beefed-up social trading tools. What's the commotion about? Well, that's your hook. These leaderboards are the newest addition to their ecosystem, paired with some serious social trading muscle. As Arkadiusz Bujalski, the Head of Ops and System...

NEXA Unlimited: Disrupting Mortgage Broker Earnings

What Exactly Is NEXA Unlimited? In a game-changer twist, NEXA Lending has launched something that could dramatically shuffle the current mortgage broker model deck. Dubbed NEXA Unlimited, this new model promises no less than 100% revenue access to its loan officers. We're talking zero fees—flat, funding, closing—none of ‘em. This isn't a small tweak or a cosmetic...

SCO at 25: China's Strategic Push for Regional Growth

There's a new beat coming out of Central Asia, and it's resonating all the way from China's boardrooms to the barren landscapes of the Gobi Desert. With the Shanghai Cooperation Organization (SCO) celebrating its 25th anniversary, we're witnessing a pivot from a security-centric setup to a full-blown economic collaboration machine. The Landscape of SCO's Evolution Look,...

M Social's NYC Edition Merges Sport and Community

A Bold Move in the Heart of Manhattan You know when a hotel chains itself to a major event like the US Open, it's looking to make a statement—bold, loud, and clear. M Social Hotel New York Times Square did just that, turning its space into a powerhouse hub of sport, culture, and community right in Times Square. Over two days, they brought together some of the top ATP...

ICOGT's Global Expansion Targets Dynamic Markets

ICOGT's Ambitious Expansion Plan When the winds of change blow, some build walls, others build wind turbines—and ICOGT is choosing the latter with its ambitious international expansion. September kicks off a new phase for INTERNATIONAL COMPANY OIL & GAS SERVICES & GENERAL TRADING L.L.C, as they lace up for a strategic sprint across key global markets, focusing heavily...

Exploring Denture to Implant Solutions with Dr. Miller

The Changing Face of Tooth Replacement Let's dive into teeth. We're talking dentures, implants, and the rest of the gang that live in the world of full mouth replacements. Dr. Christopher Glenn Miller’s insights shared with HelloNation zero in on the evolution of tooth replacement options. Gone are the days of clunky dentures being your only shot. From sucking gum to...

Syra Health Expands Public Health Wellness Initiative

Wellness Programs in Public Health: A Necessary Evolution Syra Health and Wake County Public Health are kicking off a renewed push for wellness with their Wellness S.P.A. 2.0 initiative. This isn't just a fancy rehash of their earlier project. Nope, it's a full-on effort to support those on the frontline of public health, those folks bearing the brunt of complex...

SCO Agenda: Development, Security, and Global Equity

China's Vision for a Balanced World In a world chock-full of friction and uncertainty, President Xi's proclamation at the recent SCO meeting has struck a chord. The SCO, once a fledgling idea among nations, now stands on the global stage with Xi's ringing call for it to prioritize development and equity in governance. A Subtle Shift in the Global South's Influence Xi's...

Jeen's Real-Time AI Cost Management Unveiled

Unmasking the Ghosts in AI Expenses Enterprises are thrashing around in the digital ocean of AI, yet many still can't see what's draining their coffers. It's not just the savant data scientists racking up the charges; it's every automated agent chipping away at resources—unnoticed until the bill finally lands. That's where Jeen is stepping in, flipping the script on...

MGM Resorts Unveils Star-studded Culinary Lineup for F1

Formula 1 Meets Culinary Excellence Alright, gearheads and foodies, buckle up. MGM Resorts has rolled out the red carpet for a top-notch culinary experience right at the Bellagio Fountain Club. Las Vegas isn't just about the cards and the slots anymore; they're tying the apron on some heavyweight culinary stars for the 2026 Formula 1 Heineken Las Vegas Grand Prix. If I...